CHINNASAMy et al., Orient. J. Chem., Vol. 33(4), 1856-1863 (2017)
1858
Characterization of 2, 3-diphenyl benzo [g]
quinoxaline
Characterization of 2, 3-bis(4-fluorophenyl)
benzo[g]quinoxaline
yield= 97%: Pale Brown coloured crystals:
m.p. = 99°C; FTIR: Heterocyclic -C=N & -C=C-
str.=1595.13 cm-1, aromatic –CH str.=3061.03 cm-1,
aromatic –C=C- str.=1666.50 cm-1, aromatic –C-C-
str.=1517.98 cm-1, aromatic –C-N- str. = 1325.10
cm-1; H1NMR : (400 MHz, DMSO): d = 7.946–7.925
(J = 1.9622) (t, 2H, arom.); d =7.829-7.791 (J =
1.000) (t, 2H, arom.);d = 7.660-7.621 (J = 2.0311) (t,
4H, arom.); C13NMR: (400 MHz, DMSO) d = 194.79,
135.50, 132.25, 129.66, 129.56, 129.48, 128.39,
128.01, 127.11, 40.18, 39.97, 39.76, 39.55, 39.34,
39.14, 38.93 ppm.
yield = 98%:Pale Brown coloured crystals.
m.p.= 118°C; FTIR: Heterocyclic -C=N & -C=C- str.
= 1597.06 cm-1, aromatic –C-H str. = 3074.53 cm-1,
aromatic –C=C- str. = 1666.50 cm-1, aromatic –C-C-
str. = 1506.41 cm-1, aromatic –C-N str.=1317.38
cm-1, C-F bond = 1101.35 cm-1; H1NMR (400 MHz,
DMSO) d = 8.072-8.021 (J=2.00) (m, 8H, arom.);
d = 7.497 - 7.439 (J = 2.0417) (m, 6H, arom.);
C13NMR (400 MHz, DMSO) d = 192.60, 167.51,
164.97, 133.06, 132.96, 128.99, 128.97, 116.86,
116.64, 40.11, 39.91, 39.70, 39.49, 39.28, 39.07,
38.86.
procedure for the synthesis of 2, 3-bis(4-
methylphenyl)benzo[g]quinoxaline
pharmacology
Animal subject used
In a 100 ml beaker, 2 mmol of 4,4’-
Swiss albino mice of male gender (21–24 g)
were used throughout the study.They were provided
normal pellet diet and drinking water ad libitum and
were exposed to 12 h sunlight and 12 h dark cycle.
The animals were made physiologically responsive
to the laboratory conditions prior to the experiments.
Animals’ care was taken as per guidelines of
the Committee for the Purpose of Control and
Supervision of Experiments on Animals (CPCSEA),
Environment and Forests Ministry, India.
dimethylbenzil, 2 mmol of CTAB were added to 10
ml Ethanol and placed on magnetic stirrer, added
with 2 mmol of 2,3-diaminoNapthalene in 10ml 1M
HCl, in-situ to this reaction mixture, drop by drop.
The precipitate was re-crystallized with Ethanol.
Characterization of 2, 3-bis(4-methylphenyl)
benzo[g]quinoxaline
yield = 95%:Pale Brown coloured crystals:
M.P. =107°C; FTIR :Heterocyclic -C=N str. & -C=C-
str. =1595.13 cm-1, –C-H- str. in CH3 = 2922.16 cm-1,
aromatic C-H str.=3047.53 cm-1, aromatic –C-C- str.
= 1429.25 cm-1, aromatic –C=C- str.=1662.64 cm-1,
aromatic –C-N- str.=1313.52 cm-1, , in-plane bending
of –C-H- in CH3 = 1037.70 cm-1, out of plane bending
of –C-H- in CH3 =736.81 cm-1; H1NMR:(400 MHz,
DMSO) d = 7.809-7.788 (J=2.000) (d, 8H, arom.);
d =7.441-7.420 (J = 2.0416) (d, 6H, arom.); d
=2.414 (s, 3H, in -CH3) C13NMR: (400 MHz, DMSO)
d = 194.60, 146.44, 130.03, 129.95, 129.59, 40.18,
39.97, 39.76, 39.55, 39.34, 39.13, 38.92, 21.41
ppm.
drugs used
Diazepam hydrochloride (Ranbaxy
Laboratories, Gurgaon, India) was procured and
used as a standard drug and it was diluted with
saline water to the needed strength prior to the use.
The test compounds were suspended in 0.3% w/v
of sodium carboxymethyl cellulose (CMC) and were
administered through oral gavage.
Acute Toxicity Studies
Acute Oral Toxicity (AOT 423) guideline
was followed for the acute toxicity studies of the
synthesized compounds. Briefly, overnight fasted
animals were treated with various concentrations of
the compounds to be tested (5, 50, 300 and 2000
mg/kg, bw) by oral route.The observation of animals
for any behavioral changes or mortality for first
24 h was done. The animals were maintained for
another 14 days to check the abnormal changes and
mortality. Based on the results, the dose was fixed
for pharmacological studies.
procedure for the synthesis of 2, 3-bis(4-
fluorophenyl)benzo[g]quinoxaline
In a 100 ml beaker, 2 mmol of 4,4’-
difluorobenzil, 2 mmol of CTAB were added to
10 ml Ethanol and placed on magnetic stirrer, added
with 2 mmol of 2,3-diaminoNapthalene in 10 ml 1M
HCl, in-situ to this reaction mixture, drop by drop.The
precipitate was re-crystallized with Ethanol.